Skip to main content
. 2021 Feb 1;16(2):e0245827. doi: 10.1371/journal.pone.0245827

Table 2. Patient (ITT) study exposure for all patients and patients who withdrew from the study.

ITT Population
Parameter AboBoNT-A Placebo Total
 N 89 45 134
 Mean (SD) days 67.7 (38.4) 52.5 (34.7) 62.6 (37.8)
 CI 95% 59.6; 75.8 42.1; 62.9 56.2; 69.1
 Median days 85.0 35.0 85.0
 Min; Max 1.0; 184.0 14.0; 105.0 1.0; 184.0
ITT Patients Who Withdrew From Study
 N 32 24 56
 Mean (SD) days 19.8 (8.4) 22.0 (8.6) 20.7 (8.5)
 CI 95% 16.7; 22.8 18.4; 25.6 18.4; 23.0
 Median days 15.5 18.0 16.0
 Min; Max 1.0; 37.0 14.0; 45.0 1.0; 45.0

aboBoNT-A = abobotulinumtoxinA; CI = confidence interval; ITT = intent-to-treat; SD = standard deviation.